Clinical Trial: Late Effects and HRQoL in Survivors of Allo-HSCT - a Cross Sectional Study
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Hematological Diseases
Study Type: OBSERVATIONAL
Official Title: Late Effects and Health-Related Quality of Life in Survivors of Allogeneic Hematopoietic - a Cross-sectional Study
Brief Summary:
The cross-sectional study aims to describe the burden of late effects and survivorship-specific health-related quality of life in a nationwide cohort of patients treated with allo-HSCT in Denmark.Further, identify demographic, medical or personal factors associated with better self-reported health and quality of life.
Read more